Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease

  • Aracil-Bolaños, Ignacio|||0000-0002-8246-5025
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • González-de-Echávarri, José María|||0000-0002-6130-9111
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Izquierdo, Cristina
  • Gómez Ansón, Beatriz|||0000-0001-7900-938X
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Background: Huntington's disease is a neurodegenerative disorder characterized by clinical alterations in the motor, behavioral, and cognitive domains. However, the structure and disruptions to large-scale brain cognitive networks have not yet been established. Objective: We aimed to profile changes in large-scale cognitive networks in premanifest and symptomatic patients with Huntington's disease. Methods: We prospectively recruited premanifest and symptomatic Huntington's disease mutation carriers as well as healthy controls. Clinical and sociodemographic data were obtained from all participants, and resting-state functional connectivity data, using both time-averaged and dynamic functional connectivity, was acquired from whole-brain and cognitively oriented brain parcellations. Results: A total of 64 gene mutation carriers and 23 healthy controls were included; 21 patients with Huntington's disease were classified as premanifest and 43 as symptomatic Huntington's disease. Compared with healthy controls, patients with Huntington's disease showed decreased network connectivity within the posterior hubs of the default-mode network and the medial prefrontal cortex, changes that correlated with cognitive (t = 2.25, P = 0.01) and disease burden scores (t = -2.42, P = 0.009). The salience network showed decreased functional connectivity between insular and supramarginal cortices and also correlated with cognitive (t = 2.11, P = 0.02) and disease burden scores (t = -2.35, P = 0.01). Dynamic analyses showed that network variability was decreased for default-central executive networks, a feature already present in premanifest mutation carriers (dynamic factor 8, P = 0.02). Conclusions: Huntington's disease shows an early and widespread disruption of large-scale cognitive networks. Importantly, these changes are related to cognitive and disease burden scores, and novel dynamic functional analyses uncovered subtler network changes even in the premanifest stages.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Parkinson's Disease, Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity

  • Marín Lahoz, Juan|||0000-0003-0008-2360
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • Fernandez de Bobadilla, Ramón
  • Pascual Sedano, Berta María|||0000-0002-9298-8241
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Gironell, Alexandre|||0000-0003-2109-9030
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Introduction: Impulse control disorders (ICDs) are a common complication of Parkinson's disease (PD) receiving dopamine agonist (DAA) Impulsivity is considered an underlying mechanism but evidence of this relationship is scarce. To explore the relationship between impulsivity and the presence and severity of ICD in PD. Methods: Prospective cross-sectional study of consecutive PD outpatients. Patients with dementia or previously known ICDs were excluded. Two measures of impulsivity were assessed: Barratt Impulsiveness Scale (BIS-11) for impulsiveness trait (main exposure) and commission errors in the Continuous Performance Test (CE) for motor inhibition. Main outcomes were diagnosis of ICD based on a comprehensive clinical interview and severity of ICD based on the Questionnaire for Impulsive-Compulsive Disorders. Results: Of 100 patients (mean [SD] age, 67.2 [8.8], 54 male), 31 had ICD. Patients with ICDs were 5.3 years younger (p = 0.01), used more frequently dopamine agonist (p = 0.02), alcohol (p = 0.009) and tobacco (p = 0.02). They were not more impulsive on BIS-11 (56 vs. 58, p = 0.23, adjusted p = 0.46) and CE (p = 0.96). No relationship was found between dopaminergic medications and impulsivity or ICD severity. Among patients with ICD, impulsivity was correlated with ICD severity (BIS-11 r = 0.33, p = 0.001, adjusted p = 0.002, CE r = 0.53, p = 0.006). Multivariate regression analysis confirmed the independent predictive role of both measures. Conclusions: Impulsivity is not associated with increased prevalence of ICD in PD but it is strongly linked to ICD severity. When considering dopamine replacement therapy, assessment of impulsivity may be a useful approach to detect those patients at risk of severe forms of ICD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease, Stemming the tide?

  • Aracil-Bolaños, Ignacio|||0000-0002-8246-5025
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Pujol, J.
  • Soriano-Mas, C.
  • González-de-Echávarri, José María|||0000-0002-6130-9111
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
Dopamine-replacing therapies are an effective treatment for the motor aspects of Parkinson's disease. However, its precise effect over the cognitive resting-state networks is not clear; whether dopaminergic treatment normalizes their functional connectivity-as in other networks- and the links with cognitive decline are presently unknown. We recruited 35 nondemented PD patients and 16 age-matched controls. Clinical and neuropsychological assessments were performed at baseline, and conversion to dementia was assessed in a 10 year follow-up. Structural and functional brain imaging were acquired in both the ON and practical OFF conditions. We assessed functional connectivity in both medication states compared to healthy controls, connectivity differences within participants related to the ON/OFF condition, and baseline connectivity of PD participants that converted to dementia compared to those who did not convert. PD participants showed and increased frontoparietal connectivity compared to controls: a pattern of higher connectivity between salience (SN) and default-mode (DMN) networks both in the ON and OFF states. Within PD patients, this higher SN-DMN connectivity characterized the participants in the ON state, while within-DMN connectivity prevailed in the OFF state. Interestingly, participants who converted to dementia also showed higher SN-DMN connectivity in their baseline ON scans compared to nonconverters. To conclude, PD patients showed higher frontoparietal connectivity in cognitive networks compared to healthy controls, irrespective of medication status, but dopaminergic treatment specifically promoted SN-DM hyperconnectivity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours, results from the COPPADIS cohort

  • Jesús, Silvia
  • Labrador-Espinosa, Miguel A.|||0000-0003-3576-1777
  • Adarmes-Gómez, A.D.|||0000-0002-1337-9289
  • Méndez-del Barrio, Carlota
  • Martínez-Castrillo, Juan Carlos|||0000-0001-7744-6850
  • Alonso-Cánovas, Araceli|||0000-0003-1702-2655
  • Sánchez Alonso, Pilar|||0000-0003-0496-4707
  • Novo-Ponte, Sabela
  • Alonso-Losada, Maria Gema
  • López Ariztegui, Nuria|||0000-0001-7172-3191
  • Segundo Rodríguez, José C.
  • Morales, M.I.
  • Gastón, Itziar
  • Lacruz Bescos, Francisco
  • Clavero Ibarra, Pedro
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Pascual Sedano, Berta María|||0000-0002-9298-8241
  • Martínez Martín, Pablo|||0000-0003-0837-5280
  • Santos García, Diego|||0000-0002-3126-5111
  • Mir, Pablo|||0000-0003-1656-302X
  • Aguilar Barberà, Miquel
  • Almeria, Marta|||0000-0001-7445-6113
  • Álvarez Sauco, María
  • Arnáiz, Sandra
  • Arribas, Sonia
  • Ascunce Vidondo, Arancha
  • Bernardo Lambrich, Noemí
  • Bejr-kasem, Helena|||0000-0001-8828-5976
  • Blázquez Estrada, Marta|||0000-0003-3348-9992
  • Botí, M.|||0000-0003-2963-6929
  • Borrué, Carmen
  • Cabello González, Carolina
  • Cámara, Ana|||0000-0002-8005-9461
  • Carrillo, Fátima
  • Carrillo Padilla, Francisco
  • Casas, Elena
  • Catalán Alonso, Maria José
  • Cortina Fernández, Ana
  • Cots-Foraster, Anna|||0000-0002-9169-7653
  • Crespo Cuevas, Ane Miren|||0000-0003-1400-5809
  • Cubo, Esther|||0000-0003-0018-1182
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Escalante, Sonia|||0000-0001-8931-1400
  • Erro, Elena
  • Fàbregues-Boixar i Nebot, Oriol de|||0000-0002-3518-5338
  • Fernández Guillán, Noelia
  • Gámez, Pedro
  • Gallego, Miguel|||0000-0002-8882-4033
  • García Caldentey, Juan
  • García Campos, Cristina|||0000-0003-3277-2374
  • García Moreno, José Manuel
  • Gómez Garre, María P.
  • González Aloy, Javier
  • González Ardura, Jessica
  • González García, Beatriz
  • González Palmás, María J.
  • González Toledo, G.R.
  • Golpe Díaz, Ana
  • Grau Solá, Mireia
  • Guardia, Gemma
  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Infante, Jon|||0000-0003-4025-4606
  • Kurtis, Mónica|||0000-0003-3037-9712
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Labandeira, Carmen
  • Lage Castro, Melva
  • Legarda, Inés
  • López Díaz, Luis M.
  • López Manzanares, Lydia|||0000-0003-4615-4542
  • López Seoane, Balbino
  • Macías, Yolanda
  • Mata, Marina|||0000-0001-9693-7663
  • Martí Andres, Gloria
  • Martí, María J.
  • McAfee, Darrian
  • Meitín, Maria T.
  • Menéndez González, Manuel
  • Miranda Santiago, Javier
  • Moreno Diéguez, Antonio
  • Nogueira, Víctor
  • Novo Amado, Alba
  • Ordás Bandera, Carlos Manuel|||0000-0003-3551-8769
  • Pastor, Pau|||0000-0002-7493-8777
  • Paz González, José M.
  • Pareés, Isabel|||0000-0002-6873-4823
  • Pérez Fuertes, Aída
  • Pérez Noguera, Rafael
  • Planellas, Lluis|||0000-0002-0769-6675
  • Prats, M. A.
  • Prieto Jurczynska, Cristina
  • Pueyo Morlans, Mercedes
  • Puente, Víctor
  • Redondo Rafales, Nuria
  • Rodríguez Méndez, Luisa
  • Rodríguez Pérez, A. B.
  • Roldán, Florinda
  • De Arcos, M.R.
  • Ruíz Martínez, J.
  • Sánchez-Carpintero, Macarena
  • Sánchez Díez, Gemma
  • Sánchez Rodríguez, Antonio|||0000-0002-8266-1157
  • Santacruz, Pilar
  • Seijo, Manuel
  • Serarols, A.
  • Sierra Peña, María
  • Solano Vila, Berta|||0009-0007-8945-0487
  • Suárez Castro, Ester
  • Tartari, Juan Pablo
  • Valero, Caridad
  • Vargas, Laura
  • Vázquez Gómez, R.
  • Vela, Lydia|||0000-0001-6663-395X
  • Villanueva, Clara
  • Vives-Pastor, Bárbara
  • Villar, Maria Dolores
The study was aimed at analysing the frequency of impulse control disorders (ICDs) and compulsive behaviours (CBs) in patients with Parkinson's disease (PD) and in control subjects (CS) as well as the relationship between ICDs/CBs and motor, nonmotor features and dopaminergic treatment in PD patients. Data came from COPPADIS-2015, an observational, descriptive, nationwide (Spain) study. We used the validated Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) for ICD/CB screening. The association between demographic data and ICDs/CBs was analyzed in both groups. In PD, this relationship was evaluated using clinical features and treatment-related data. As result, 613 PD patients (mean age 62.47 ± 9.09 years, 59.87% men) and 179 CS (mean age 60.84 ± 8.33 years, 47.48% men) were included. ICDs and CBs were more frequent in PD (ICDs 12.7% vs. 1.6%, p < 0.001; CBs 7.18% vs. 1.67%, p = 0.01). PD patients had more frequent previous ICDs history, premorbid impulsive personality and antidepressant treatment (p < 0.05) compared with CS. In PD, patients with ICDs/CBs presented younger age at disease onset, more frequent history of previous ICDs and premorbid personality (p < 0.05), as well as higher comorbidity with nonmotor symptoms, including depression and poor quality of life. Treatment with dopamine agonists increased the risk of ICDs/CBs, being dose dependent (p < 0.05). As conclusions, ICDs and CBs were more frequent in patients with PD than in CS. More nonmotor symptoms were present in patients with PD who had ICDs/CBs compared with those without. Dopamine agonists have a prominent effect on ICDs/CBs, which could be influenced by dose.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early gray matter volume loss in MAPT H1H1 de Novo PD patients, A possible association with cognitive decline

  • Sampedro, Frederic|||0000-0002-3933-1355
  • Marín Lahoz, Juan|||0000-0003-0008-2360
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
The MAPT H1 haplotype has been identified as a predictor of cognitive decline in Parkinson's disease (PD). However, its underlying pathological mechanisms have not been fully established. In this work, using a cohort of 120 de novo PD patients with preserved cognition from the Parkinson's Progression Markers Initiative (PPMI) database, we found that patients who were homozygous for MAPT H1 had less gray matter volume (GMV) and greater 1-year GMV loss than patients without this genetic profile. Importantly, these changes were associated with a longitudinal worsening of cognitive indicators. Our findings suggest that early GMV loss in MAPT H1H1 PD patients increases their risk to develop cognitive decline.